{"title":"Serum magnesium in association with parathyroid hormone levels in routine hemodialysis patients","authors":"Milad Fooladgar, A. Malekpour, Shahin Asgari-Savadjani, Saeed Mardani","doi":"10.15171/JPD.2018.05","DOIUrl":null,"url":null,"abstract":"Abstract \nIntroduction: The homeostasis of magnesium (Mg) is perturbed in chronic kidney disease. It has been supposed that plasma Mg \nhas a principal role to regulate the secretion of parathyroid hormone (PTH). Plasma Mg is capable of modulating secretion of PTH. \nRecent investigations showed that low serum Mg levels in patients with kidney disease have been linked to increased mortality. \nObjectives: The aim of this study was to determine the relationship between serum Mg and PTH levels in hemodialysis patients. \nPatients and Methods: This cross-sectional study was conducted on 56 hemodialysis patients in hemodialysis center of Hajar hospital \nof Shahrekord in 2015. Regular hemodialysis patients who had at least three months history of dialysis were enrolled to the study. \nThe serum levels of Mg, calcium, phosphorus, intact PTH (iPTH), alkaline phosphatase, albumin and bicarbonate were measured. \nResults: In this study, 61.5% of the 52 patients were male. Mean ± standard deviation (SD) of patients’ age was 60.5 ± 17.7 years \nwith median of 63 years old. The average duration of dialysis was 44±39.5 months (median 36 months). Additionally the dialysis \ndose was 517 ± 479 weeks (median; 414 weeks). Mean ± SD of serum iPTH and Mg were 360.1 ± 238.2 pg/mL and 2.2 ± 0.2 mg/mL \nrespectively. In this study we found a significantly positive correlation of iPTH with serum Mg levels (r=0.28, P=0.04). \nConclusion: This study shows impact of Mg on parathormone secretion. Our findings require further investigations with larger and \nmulticentric studies. \nPlease cite this paper as: Fooladgar M, Malekpour A, Asgari-Savadjani S, Mardani S. Serum magnesium in association with \nparathyroid hormone levels in routine hemodialysis patients. J Parathyr Dis. 2018;6(1):13-15. DOI: 10.15171/jpd.2018.05. \nCopyright © 2018 The Author(s); Published by Nickan Research Institute. This is an open-access article distributed under the terms \nof the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, \nprovided the original work is","PeriodicalId":16657,"journal":{"name":"Journal of Parathyroid Disease","volume":"73 1","pages":"13-15"},"PeriodicalIF":0.0000,"publicationDate":"2017-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Parathyroid Disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15171/JPD.2018.05","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 4
常规血液透析患者血清镁与甲状旁腺激素水平的关系
摘要简介:慢性肾脏疾病患者体内镁(Mg)的稳态受到干扰。血浆Mg被认为在调节甲状旁腺激素(PTH)的分泌中起主要作用。血浆Mg能够调节甲状旁腺激素的分泌。最近的调查显示,肾脏疾病患者血清Mg水平低与死亡率增加有关。目的:本研究的目的是确定血液透析患者血清Mg和甲状旁腺激素水平之间的关系。患者与方法:对2015年在Shahrekord市Hajar医院血液透析中心进行的56例血液透析患者进行横断面研究。有至少三个月透析史的定期血液透析患者被纳入研究。测定血清Mg、钙、磷、完整甲状旁腺素(iPTH)、碱性磷酸酶、白蛋白和碳酸氢盐水平。结果:本组52例患者中男性占61.5%。患者年龄的平均±标准差(SD)为60.5±17.7岁,中位年龄为63岁。平均透析时间为44±39.5个月(中位36个月)。此外,透析剂量为517±479周(中位;414周)。血清iPTH和Mg的平均值±SD分别为360.1±238.2 pg/mL和2.2±0.2 Mg /mL。本研究发现iPTH与血清Mg水平呈显著正相关(r=0.28, P=0.04)。结论:本研究显示Mg对甲状旁激素分泌的影响。我们的发现需要更大规模的多中心研究来进一步调查。请引用本文:Fooladgar M, Malekpour A, Asgari-Savadjani S, Mardani S.血镁与常规血液透析患者甲状旁腺激素水平的关系。植物病理学杂志,2018;6(1):13-15。DOI: 10.15171 / jpd.2018.05。版权所有©2018作者;由尼克研究所出版。这是一篇根据知识共享署名许可协议发布的开放获取文章,该协议允许在任何媒体上不受限制地使用、分发和复制,前提是原创作品是
本文章由计算机程序翻译,如有差异,请以英文原文为准。